224 related articles for article (PubMed ID: 36868166)
1. Human papillomavirus in cancer: Infection, disease transmission, and progress in vaccines.
Oyouni AAA
J Infect Public Health; 2023 Apr; 16(4):626-631. PubMed ID: 36868166
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and Distribution of Vaccine-Preventable Genital Human Papillomavirus(HPV) Genotypes in Ghanaian Women Presenting for Screening.
Donkoh ET; Asmah RH; Agyemang-Yeboah F; Dabo EO; Wiredu EK
Cancer Control; 2022; 29():10732748221094721. PubMed ID: 35536890
[TBL] [Abstract][Full Text] [Related]
3. Cervical cancer in Ethiopia: a review of the literature.
Derbie A; Mekonnen D; Nibret E; Misgan E; Maier M; Woldeamanuel Y; Abebe T
Cancer Causes Control; 2023 Jan; 34(1):1-11. PubMed ID: 36242682
[TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus infections in children: the potential role of maternal transmission.
Syrjänen S; Puranen M
Crit Rev Oral Biol Med; 2000; 11(2):259-74. PubMed ID: 12002819
[TBL] [Abstract][Full Text] [Related]
5. [Epidemiology of cervical papillomavirus infections. Recent knowledge].
Mougin C; Dalstein V; Prétet JL; Gay C; Schaal JP; Riethmuller D
Presse Med; 2001 Jun; 30(20):1017-23. PubMed ID: 11433694
[TBL] [Abstract][Full Text] [Related]
6. Oral immunization with bacteriophage MS2-L2 VLPs protects against oral and genital infection with multiple HPV types associated with head & neck cancers and cervical cancer.
Zhai L; Yadav R; Kunda NK; Anderson D; Bruckner E; Miller EK; Basu R; Muttil P; Tumban E
Antiviral Res; 2019 Jun; 166():56-65. PubMed ID: 30926288
[TBL] [Abstract][Full Text] [Related]
7. Biology and pathological associations of the human papillomaviruses: a review.
Cheah PL; Looi LM
Malays J Pathol; 1998 Jun; 20(1):1-10. PubMed ID: 10879257
[TBL] [Abstract][Full Text] [Related]
8. The human papillomavirus replication cycle, and its links to cancer progression: a comprehensive review.
Graham SV
Clin Sci (Lond); 2017 Sep; 131(17):2201-2221. PubMed ID: 28798073
[TBL] [Abstract][Full Text] [Related]
9. Human papillomavirus: current status and issues of vaccination.
Malik H; Khan FH; Ahsan H
Arch Virol; 2014 Feb; 159(2):199-205. PubMed ID: 24022639
[TBL] [Abstract][Full Text] [Related]
10. Carcinogenesis Associated with Human Papillomavirus Infection. Mechanisms and Potential for Immunotherapy.
Vonsky M; Shabaeva M; Runov A; Lebedeva N; Chowdhury S; Palefsky JM; Isaguliants M
Biochemistry (Mosc); 2019 Jul; 84(7):782-799. PubMed ID: 31509729
[TBL] [Abstract][Full Text] [Related]
11. High prevalence of genital HPV infection among long-term monogamous partners of women with cervical dysplasia or genital warts-Another reason for HPV vaccination of boys.
Rob F; Tachezy R; Pichlík T; Rob L; Kružicová Z; Hamšíková E; Šmahelová J; Hercogová J
Dermatol Ther; 2017 Jan; 30(1):. PubMed ID: 27723194
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of vaccine and non-vaccine human papillomavirus types among women in Accra and Kumasi, Ghana: a cross-sectional study.
Debrah O; Agyemang-Yeboah F; Donkoh ET; Asmah RH
BMC Womens Health; 2021 Oct; 21(1):372. PubMed ID: 34702246
[TBL] [Abstract][Full Text] [Related]
13. HPV genotypic spectrum in Jilin province, China, where non-vaccine-covered HPV53 and 51 are prevalent, exhibits a bimodal age-specific pattern.
Hao S; Wang C; Liu S; He J; Jiang Y
PLoS One; 2020; 15(3):e0230640. PubMed ID: 32208459
[TBL] [Abstract][Full Text] [Related]
14. [Human papillomavirus prophylactic vaccines: stakes and perspectives].
Hantz S; Alain S; Denis F
Gynecol Obstet Fertil; 2006; 34(7-8):647-55. PubMed ID: 16807045
[TBL] [Abstract][Full Text] [Related]
15. Potential coverage of circulating HPV types by current and developing vaccines in a group of women in Bosnia and Herzegovina with abnormal Pap smears.
Salimović-Bešić I; Hukić M
Epidemiol Infect; 2015 Sep; 143(12):2604-12. PubMed ID: 25578155
[TBL] [Abstract][Full Text] [Related]
16. High-risk human papillomavirus genotypes in cervical lesions and vaccination challenges in China.
Xu QX; Zhang ZY
Asian Pac J Cancer Prev; 2015; 16(6):2193-7. PubMed ID: 25824736
[TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus genotype attribution for HPVs 6, 11, 16, 18, 31, 33, 45, 52 and 58 in female anogenital lesions.
Serrano B; de Sanjosé S; Tous S; Quiros B; Muñoz N; Bosch X; Alemany L
Eur J Cancer; 2015 Sep; 51(13):1732-41. PubMed ID: 26121913
[TBL] [Abstract][Full Text] [Related]
18. The potential impact of prophylactic human papillomavirus vaccination on oropharyngeal cancer.
Guo T; Eisele DW; Fakhry C
Cancer; 2016 Aug; 122(15):2313-23. PubMed ID: 27152637
[TBL] [Abstract][Full Text] [Related]
19. Genomic diversity of human papillomaviruses (HPV) and clinical implications: an overview in adulthood and childhood.
Mammas IN; Spandidos DA; Sourvinos G
Infect Genet Evol; 2014 Jan; 21():220-6. PubMed ID: 24291228
[TBL] [Abstract][Full Text] [Related]
20. Incidence and duration of type-specific human papillomavirus infection in high-risk HPV-naïve women: results from the control arm of a phase II HPV-16/18 vaccine trial.
Ramanakumar AV; Naud P; Roteli-Martins CM; de Carvalho NS; de Borba PC; Teixeira JC; Blatter M; Moscicki AB; Harper DM; Romanowski B; Tyring SK; Ramjattan B; Schuind A; Dubin G; Franco EL;
BMJ Open; 2016 Aug; 6(8):e011371. PubMed ID: 27566633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
